Related Experiment Videos
[Japan Arteriosclerosis Longitudinal Study]
Yasuo Ohashi1, Hirotsugu Ueshima, Akiko Harada
1Department of Biostatistics/Epidemiology and Preventive Health Sciences, Graduate School of Medicine, University of Tokyo.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|September 20, 2006
Summary
No abstract available in PubMed .
Related Concept Videos
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
Comparative long-term prognosis of acute myocardial infarction and acute aortic dissection in a population-based registry.
European heart journal open·2026
Same author
Investigation of a storage method for peritoneal and pleural effusion cytology specimens for long-term preservation of antigenicity in immunocytochemical staining.
Acta cytologica·2026
Same author
Long-term cardiovascular mortality risk of hyperuricemia and chronic kidney disease in a general Japanese population: NIPPON DATA90.
Endocrine·2026
Same author
[Home care duration and service use among elderly patients with terminal cancer in Japan: A nationwide study using the Japanese Long-Term Care Insurance Claims].
[Nihon koshu eisei zasshi] Japanese journal of public health·2026
Same author
Loss of both wobbleU<sub>34</sub> modifications in mcm<sup>5</sup>s<sup>2</sup>U tRNAs impairs rRNA biosynthesis, growth, and development in <i>Arabidopsis thaliana</i>.
Frontiers in plant science·2025
Same author
The Second Mitochondria-Derived Activator of Caspases Mimetic BI 891065 in Patients With Advanced Solid Tumors: Results From Two Phase I Studies.
Cancer medicine·2025
Same journal
[Development of novel therapeutics for multiple myeloma and improvement of drug lag].
Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal
[Clinical pharmacy services to patients of immunomodulatory drugs].
Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal
[Therapeutic drug monitoring of the new anti-myeloma drugs in the treatment of multiple myeloma].
Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal
[Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].
Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal
[The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].
Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal
[Evaluation of minimal residual disease in myeloma by multiparametric flow cytometry].
Nihon rinsho. Japanese journal of clinical medicine·2019